Tobira Therapeutics, Inc. Common Stock
TBRA
TBRA was delisted on the 31st of October, 2016.
15 hedge funds and large institutions have $15.4M invested in Tobira Therapeutics, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$9.66M |
| 2 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$2.08M |
| 3 |
Morgan Stanley
New York
|
+$447K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$384K |
| 5 |
SIM
Spark Investment Management
New York
|
+$167K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BI
1
BVF Inc
San Francisco,
California
| $11.1M | +$9.66M | +184,343 | New |
|
|
WC
2
Wexford Capital
West Palm Beach,
Florida
| $2.38M | +$2.08M | +39,599 | New |
|
|
3
Morgan Stanley
New York
| $514K | +$447K | +8,536 | New |
|
|
4
Alyeska Investment Group
Chicago,
Illinois
| $442K | +$384K | +7,335 | New |
|
|
SIM
5
Spark Investment Management
New York
| $190K | +$167K | +3,189 | New |
|
6
Goldman Sachs
New York
| $181K | +$158K | +3,010 | New |
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $181K | +$158K | +3,020 | New |
|
|
VKH
8
Virtu KCG Holdings
New York
| $155K | +$136K | +2,592 | New |
|
9
Geode Capital Management
Boston,
Massachusetts
| $102K | +$88.6K | +1,691 | New |
|
10
Jane Street
New York
| $98K | +$85K | +1,622 | New |
|
11
Bank of America
Charlotte,
North Carolina
| $35K | +$30.3K | +579 | New |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| $9K | +$7.91K | +151 | New |
|
13
Citigroup
New York
| $8K | +$7.13K | +136 | New |
|
|
OIA
14
Optimum Investment Advisors
Chicago,
Illinois
| $7K | +$5.82K | +111 | New |
|
|
U
15
UBS
Zurich,
Switzerland
| $3K | +$2.62K | +50 | New |
|
TBRA Hedge Fund Activity: Q3 2013 in Review
15 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Tobira Therapeutics, Inc. Common Stock (TBRA) for Q3 2013, worth a combined $15.4M.
Buyers outnumbered sellers: 15 funds opened new TBRA positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was BVF Inc, opening a new position worth an estimated $9.66M.
- 15 institutional investors held Tobira Therapeutics, Inc. Common Stock (TBRA) as of Q3 2013, up from 0 in Q2 2013.
- Funds reported $15.4M of Tobira Therapeutics, Inc. Common Stock stock for Q3 2013.
- 15 funds opened new Tobira Therapeutics, Inc. Common Stock positions in Q3 2013 and 0 closed out, a net change of +15 holders.
- The largest Tobira Therapeutics, Inc. Common Stock buyer in Q3 2013 was BVF Inc, an estimated $9.66M added.
Based on aggregated 13F filings for Q3 2013.